Results after an additional 48 weeks: Continued semaglutide: Additional 7.9% weight loss (17.4% total from baseline) Switched to placebo: Regained about two-thirds of lost weight This trial provides crucial evidence that Wegovy requires ongoing use to maintain results
This titration schedule is designed to limit side effectssuch as nausea or gastrointestinal discomfortthat can otherwise make it difficult to stay on treatment
For patients with a history of emotional eating, binge eating, or yo-yo dieting, this rebound in cravings can be especially difficult
A: It's possible for semaglutide to interact with certain dietary supplements
Solutions like MeAgain centralize injection logs, symptom entries, hydration and protein tracking, and side-effect notes, giving clinicians a clear timeline
As of January 6, 2025, the Wegovy pill is available in the US, and you can get it through Ro (if appropriate, of course)